OncoMed Pharmaceuticals Inc Insider Trading for April 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in OncoMed Pharmaceuticals Inc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in OncoMed Pharmaceuticals Inc for April 2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 29 2015 | OMED | OncoMed Pharmaceut ... | Hager Alicia J. | VP & General Counse ... | Option Exercise | M | 3.42 | 1,800 | 6,156 | 19,252 | |
| Apr 29 2015 | OMED | OncoMed Pharmaceut ... | Hager Alicia J. | VP & General Counse ... | Sell | S | 26.19 | 855 | 22,392 | 15,000 | 15.9 K to 15 K (-5.39 %) |
| Apr 29 2015 | OMED | OncoMed Pharmaceut ... | Hager Alicia J. | VP & General Counse ... | Sell | S | 25.16 | 945 | 23,780 | 15,855 | 16.8 K to 15.9 K (-5.62 %) |
| Apr 29 2015 | OMED | OncoMed Pharmaceut ... | Hager Alicia J. | VP & General Counse ... | Buy | M | 3.42 | 1,800 | 6,156 | 16,800 | 15 K to 16.8 K (+12.00 %) |
| Apr 29 2015 | OMED | OncoMed Pharmaceut ... | Hoey Timothy | SVP, Cancer Biology | Option Exercise | M | 1.43 | 5,000 | 7,150 | 30,263 | |
| Apr 29 2015 | OMED | OncoMed Pharmaceut ... | Hoey Timothy | SVP, Cancer Biology | Sell | S | 26.20 | 3,350 | 87,781 | 49,343 | 52.7 K to 49.3 K (-6.36 %) |
| Apr 29 2015 | OMED | OncoMed Pharmaceut ... | Hoey Timothy | SVP, Cancer Biology | Sell | S | 25.12 | 3,537 | 88,864 | 52,693 | 56.2 K to 52.7 K (-6.29 %) |
| Apr 29 2015 | OMED | OncoMed Pharmaceut ... | Hoey Timothy | SVP, Cancer Biology | Buy | M | 1.43 | 5,000 | 7,150 | 56,230 | 51.2 K to 56.2 K (+9.76 %) |
| Apr 22 2015 | OMED | OncoMed Pharmaceut ... | LASERSOHN JACK W | Director | Buy | J | 0.00 | 960 | 0 | 651,713 | 650.8 K to 651.7 K (+0.15 %) |
| Apr 22 2015 | OMED | OncoMed Pharmaceut ... | LASERSOHN JACK W | Director | Buy | J | 0.00 | 3,840 | 0 | 1,669,279 | 1.7 M to 1.7 M (+0.23 %) |
| Apr 20 2015 | OMED | OncoMed Pharmaceut ... | Gurney Austin | See Remarks | Sell | S | 26.52 | 150 | 3,978 | 67,419 | 67.6 K to 67.4 K (-0.22 %) |
| Apr 20 2015 | OMED | OncoMed Pharmaceut ... | Gurney Austin | See Remarks | Sell | S | 25.47 | 3,850 | 98,072 | 67,569 | 71.4 K to 67.6 K (-5.39 %) |
| Apr 14 2015 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Option Exercise | M | 4.56 | 1,500 | 6,840 | 158,937 | |
| Apr 14 2015 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Sell | S | 26.51 | 1,500 | 39,765 | 22,377 | 23.9 K to 22.4 K (-6.28 %) |
| Apr 14 2015 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Buy | M | 4.56 | 1,500 | 6,840 | 23,877 | 22.4 K to 23.9 K (+6.70 %) |
| Apr 03 2015 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Option Exercise | M | 1.43 | 8,500 | 12,155 | 23,277 | |
| Apr 03 2015 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Option Exercise | M | 1.43 | 8,500 | 12,155 | 31,777 | |
| Apr 03 2015 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Sell | S | 25.70 | 1,560 | 40,089 | 21,285 | 22.8 K to 21.3 K (-6.83 %) |
| Apr 03 2015 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Sell | S | 25.29 | 6,940 | 175,515 | 22,845 | 29.8 K to 22.8 K (-23.30 %) |
| Apr 03 2015 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Buy | M | 1.43 | 8,500 | 12,155 | 29,785 | 21.3 K to 29.8 K (+39.93 %) |
| Apr 03 2015 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Sell | S | 25.19 | 8,500 | 214,105 | 21,285 | 29.8 K to 21.3 K (-28.54 %) |
| Apr 03 2015 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Buy | M | 1.43 | 8,500 | 12,155 | 29,785 | 21.3 K to 29.8 K (+39.93 %) |